Black Diamond Therapeutics Inc (NASDAQ: BDTX) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Black Diamond Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Black Diamond Therapeutics Inc is $127.31M. A total of 1.96 million shares were traded on the day, compared to an average of 714.16K shares.

In the most recent transaction, Versant Venture Capital VI, L. sold 221,600 shares of BDTX for 6.32 per share on Aug 28 ’24. After the transaction, the 10% Owner now owns 3,726,341 company shares. In a previous transaction on Jul 31 ’24, David Epstein bought 50,000 shares at 6.20 per share.

Among the insiders who bought shares, David Epstein acquired of 50,000 shares on Jul 26 ’24 at a per-share price of $6.20.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, BDTX has a high of $7.66 and a low of $1.91.

As of this writing, BDTX has an earnings estimate of -$0.31 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.21 per share and a lower estimate of -$0.36.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BDTX’s latest balance sheet shows that the firm has $209.79M in Cash & Short Term Investments as of fiscal 2021. There were $28.46M in debt and $23.64M in liabilities at the time. Its Book Value Per Share was $1.72, while its Total Shareholder’s Equity was $195.90M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BDTX is Buy with a score of 4.86.

Most Popular

Related Posts